CIK 0001756262 · Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- Phone
- 9785520900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −417 | 12,098 | ||
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,083 | 18,417 | ||
| 2024-09-16 | Hassanein Waleed H President & CEO | Option exercise 10b5-1 | +8,625 | $13.28 | $115K | 70,268 |
| 2024-09-16 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −908 | $151.10 | $137K | 69,360 |
| 2024-09-16 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −1,865 | $152.30 | $284K | 67,495 |
| 2024-09-16 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −3,155 | $153.32 | $484K | 64,340 |
| 2024-09-16 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −1,383 | $154.16 | $213K | 62,957 |
| 2024-09-16 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −688 | $155.65 | $107K | 62,269 |
| 2024-09-16 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −626 | $156.48 | $98K | 61,643 |
| 2024-09-16 | Hassanein Waleed H President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,625 | 104,875 | ||
| 2024-09-13 | TOBIN JAMES R Director | Gift | −18,000 | 155,146 | ||
| 2024-09-13 | TOBIN JAMES R Director | Gift | +18,000 | 18,000 | ||
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +1,459 | $38.46 | $56K | 22,302 |
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +417 | $66.10 | $28K | 22,719 |
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +1,084 | $13.28 | $14K | 23,803 |
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −599 | $157.27 | $94K | 23,204 |
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −921 | $158.09 | $146K | 22,283 |
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −132 | $159.02 | $21K | 22,151 |
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −396 | $160.67 | $64K | 21,755 |
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −700 | $161.54 | $113K | 21,055 |
Page 7 of 20 · 390 trades